Literature DB >> 3906039

Three immunity types of klebicins which use the cloacin DF13 receptor of Klebsiella pneumoniae.

P C Cooper, R James.   

Abstract

We have investigated a group of bacteriocinogenic strains used in the epidemiological investigation of Klebsiella infections. Transfer of plasmids from these strains to laboratory strains allowed the identification of three klebicins which use the cloacin DF13 receptor in Klebsiella, but are of three distinct immunity types. These klebicins use the ferric-aerobactin receptor determined by ColV-K30 in Escherichia coli, which is also used by cloacin DF13. We propose to call them group A klebicins, of immunity types A1, A2 and A3. On the basis of immunity, cloacin DF13 also belongs to the klebicin A1 group.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3906039     DOI: 10.1099/00221287-131-9-2313

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  5 in total

1.  Sensitivity of Escherichia coli to cloacin DF13 involves the major outer membrane protein OmpF.

Authors:  K G Wooldridge; P H Williams
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

2.  Effect of various inducing agents on bacteriocin (klebocin) production by Klebsiella pneumoniae.

Authors:  S Chhibber; D V Vadehra
Journal:  Folia Microbiol (Praha)       Date:  1987       Impact factor: 2.099

3.  Phage associated bacteriocins reveal a novel mechanism for bacteriocin diversification in Klebsiella.

Authors:  Milind Chavan; Hamid Rafi; John Wertz; Carla Goldstone; Margaret A Riley
Journal:  J Mol Evol       Date:  2005-04       Impact factor: 2.395

4.  Iron, siderophores, and the pursuit of virulence: independence of the aerobactin and enterochelin iron uptake systems in Escherichia coli.

Authors:  P H Williams; N H Carbonetti
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

Review 5.  Colicin biology.

Authors:  Eric Cascales; Susan K Buchanan; Denis Duché; Colin Kleanthous; Roland Lloubès; Kathleen Postle; Margaret Riley; Stephen Slatin; Danièle Cavard
Journal:  Microbiol Mol Biol Rev       Date:  2007-03       Impact factor: 11.056

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.